3151 — Vital Ksk Holdings Balance Sheet
0.000.00%
- ¥59bn
- ¥45bn
- ¥600bn
- 35
- 97
- 52
- 69
Annual balance sheet for Vital Ksk Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 29,784 | 26,971 | 19,029 | 34,712 | 23,099 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 129,899 | 136,100 | 135,010 | 134,279 | 128,914 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 190,634 | 198,532 | 188,502 | 203,303 | 187,896 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 44,686 | 45,761 | 49,024 | 49,704 | 49,168 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 311,401 | 313,033 | 297,316 | 317,258 | 299,426 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 178,426 | 190,092 | 178,659 | 193,407 | 174,880 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 208,457 | 214,072 | 198,330 | 212,594 | 193,513 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 102,944 | 98,961 | 98,986 | 104,664 | 105,913 |
Total Liabilities & Shareholders' Equity | 311,401 | 313,033 | 297,316 | 317,258 | 299,426 |
Total Common Shares Outstanding |